# LYAR

## Overview
LYAR is a gene that encodes the Ly1 antibody reactive protein, a nucleolar protein involved in critical cellular processes such as ribosome biogenesis and gene expression regulation. The protein is characterized by a unique zinc finger motif, which facilitates its DNA-binding capability, and contains multiple nuclear localization signals that enable its nuclear presence. Functionally, Ly1 antibody reactive protein plays a pivotal role in the transcriptional regulation of ribosomal DNA and globin genes, interacting with various proteins to modulate chromatin structure and gene expression. Its involvement in these processes underscores its significance in cellular growth and development. Clinically, alterations in LYAR expression or function have been associated with conditions such as β-thalassemia and potentially cancer, highlighting its importance in both normal physiology and disease states (Ju2014Human; Izumikawa2019LYAR; Su1993LYAR).

## Structure
The LYAR protein is characterized by a 1164-bp open reading frame encoding 388 amino acids, featuring a unique zinc finger motif within the first 60 amino acids. This motif is part of a new family of zinc finger proteins with a C4HC3 motif at the amino terminus, which is involved in DNA interaction and cell proliferation (Su1993LYAR). The zinc finger domain is crucial for its DNA-binding capability, and the protein is known to bind specific DNA sequences, such as GGTTAT, through this domain (Izumikawa2019LYAR).

LYAR contains three nuclear localization signals (NLS), including one similar to the SV40 T antigen and two bipartite NLS similar to those in nucleoplasmin and the thyroid receptor, facilitating its nuclear localization (Su1993LYAR). The protein also has a potential tyrosine phosphorylation site following the second zinc finger and a serine residue for cAMP-dependent protein kinase at the carboxyl terminus, indicating possible post-translational modifications (Su1993LYAR).

The tertiary structure of LYAR likely involves the folding of its zinc finger motifs into a stable configuration, typical of proteins with DNA-binding functions. The protein's quaternary structure and potential splice variant isoforms are not detailed in the available context.

## Function
The LYAR gene encodes a nucleolar protein that plays a significant role in ribosomal RNA (rRNA) synthesis and gene expression regulation in human cells. LYAR is involved in the transcriptional regulation of ribosomal DNA (rDNA) by recruiting proteins such as BRD2, BRD4, and the MYST-type acetyltransferase KAT7 to rDNA loci. This recruitment enhances the acetylation of histones H3 and H4, facilitating chromatin relaxation and promoting rRNA synthesis (Izumikawa2019LYAR). LYAR's interaction with these proteins is crucial for the transcription of 47S/45S pre-rRNA, a precursor in ribosome biogenesis (Izumikawa2019LYAR).

In addition to its role in rRNA synthesis, LYAR is implicated in the regulation of globin gene expression. It acts as a repressor of the γ-globin gene by interacting with PRMT5, a methyltransferase, and binding to specific DNA motifs in the γ-globin promoter. This interaction is essential for the silencing of the γ-globin gene during erythroid differentiation (Ju2014Human). LYAR's activity is primarily localized in the nucleolus, where it influences cellular growth and development through its involvement in ribosome biogenesis and gene expression regulation (Su1993LYAR).

## Clinical Significance
Mutations and alterations in the expression of the LYAR gene have significant clinical implications, particularly in the context of β-thalassemia and potentially in cancer. In β-thalassemia, a specific polymorphism, rs368698783 (G>A), affects LYAR's binding efficiency to the Aγ-globin gene. This mutation is associated with increased fetal hemoglobin (HbF) production, which can ameliorate the clinical severity of β-thalassemia by compensating for defective β-globin production (Zuccato2023The; Gemmo2019Surface). The presence of this polymorphism in β-thalassemia patients is linked to a higher response to HbF inducers, suggesting its potential as a marker for personalized therapy (Zuccato2023The).

LYAR is also implicated in cancer due to its role in cell proliferation and differentiation. Overexpression of LYAR may contribute to tumorigenesis by promoting uncontrolled cell growth, as it is involved in ribosome biogenesis and cell cycle regulation. Although specific cancers are not detailed in the provided context, alterations in LYAR expression or function could be linked to various cancers, including leukemia and solid tumors, due to its fundamental role in cellular processes (Ju2014Human).

## Interactions
LYAR (Ly1 antibody reactive) is a nucleolar protein that participates in various interactions with other proteins and nucleic acids, playing a significant role in cellular processes such as ribosome biogenesis and gene expression regulation. LYAR interacts with nucleophosmin/B23, nucleolin, DDX21, and treacle, which are involved in rDNA transcription (Izumikawa2019LYAR). It forms complexes with BRD2 and BRD4, members of the BET family, and the MYST-type acetyltransferase KAT7, facilitating histone acetylation and enhancing rDNA transcription (Izumikawa2019LYAR). LYAR recruits BRD2 and KAT7 to rDNA loci, which is crucial for the acetylation of histones H3 and H4, promoting transcriptional activation (Izumikawa2019LYAR).

LYAR also interacts with PRMT5, a methyltransferase, to regulate human fetal globin gene expression. This interaction is mediated by specific amino acids in LYAR and involves binding to the γ-globin promoter, affecting histone marks in the promoter region (Ju2014Human). Additionally, LYAR interacts with phosphorylated IRF3, suppressing the activation of the IFN-β promoter by impairing IRF3's DNA binding ability (Yang2019LYAR). These interactions highlight LYAR's multifaceted role in transcriptional regulation and cellular function.


## References


[1. (Izumikawa2019LYAR) Keiichi Izumikawa, Hideaki Ishikawa, Harunori Yoshikawa, Sally Fujiyama, Akira Watanabe, Hiroyuki Aburatani, Hiroyuki Tachikawa, Toshiya Hayano, Yutaka Miura, Toshiaki Isobe, Richard J Simpson, Li Li, Jinrong Min, and Nobuhiro Takahashi. Lyar potentiates rrna synthesis by recruiting brd2/4 and the myst-type acetyltransferase kat7 to rdna. Nucleic Acids Research, 47(19):10357–10372, September 2019. URL: http://dx.doi.org/10.1093/nar/gkz747, doi:10.1093/nar/gkz747. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkz747)

[2. (Su1993LYAR) L Su, R J Hershberger, and I L Weissman. Lyar, a novel nucleolar protein with zinc finger dna-binding motifs, is involved in cell growth regulation. Genes &amp; Development, 7(5):735–748, May 1993. URL: http://dx.doi.org/10.1101/gad.7.5.735, doi:10.1101/gad.7.5.735. This article has 51 citations.](https://doi.org/10.1101/gad.7.5.735)

[3. (Yang2019LYAR) Cha Yang, Xiaokun Liu, Tailang Cheng, Rong Xiao, Qingxia Gao, Fan Ming, Meilin Jin, Huanchun Chen, and Hongbo Zhou. Lyar suppresses beta interferon induction by targeting phosphorylated interferon regulatory factor 3. Journal of Virology, November 2019. URL: http://dx.doi.org/10.1128/jvi.00769-19, doi:10.1128/jvi.00769-19. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.00769-19)

[4. (Zuccato2023The) Cristina Zuccato, Lucia Carmela Cosenza, Matteo Zurlo, Giulia Breveglieri, Nicoletta Bianchi, Ilaria Lampronti, Jessica Gasparello, Chiara Scapoli, Monica Borgatti, Alessia Finotti, and Roberto Gambari. The rs368698783 (g&gt;a) polymorphism affecting lyar binding to the aγ-globin gene is associated with high fetal hemoglobin (hbf) in β-thalassemia erythroid precursor cells treated with hbf inducers. International Journal of Molecular Sciences, 24(1):776, January 2023. URL: http://dx.doi.org/10.3390/ijms24010776, doi:10.3390/ijms24010776. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24010776)

[5. (Gemmo2019Surface) Chiara Gemmo, Giulia Breveglieri, Giovanni Marzaro, Ilaria Lampronti, Lucia Carmela Cosenza, Jessica Gasparello, Cristina Zuccato, Enrica Fabbri, Monica Borgatti, Adriana Chilin, Alessia Finotti, and Roberto Gambari. Surface plasmon resonance based analysis of the binding of lyar protein to the rs368698783 (g&gt;a) polymorphic aγ-globin gene sequences mutated in β-thalassemia. Analytical and Bioanalytical Chemistry, 411(29):7699–7707, July 2019. URL: http://dx.doi.org/10.1007/s00216-019-01987-9, doi:10.1007/s00216-019-01987-9. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00216-019-01987-9)

[6. (Ju2014Human) Junyi Ju, Ying Wang, Ronghua Liu, Yichong Zhang, Zhen Xu, Yadong Wang, Yupeng Wu, Ming Liu, Loretta Cerruti, Fengwei Zou, Chi Ma, Ming Fang, Renxiang Tan, Stephen M. Jane, and Quan Zhao. Human fetal globin gene expression is regulated by lyar. Nucleic Acids Research, 42(15):9740–9752, August 2014. URL: http://dx.doi.org/10.1093/nar/gku718, doi:10.1093/nar/gku718. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gku718)